221 related articles for article (PubMed ID: 25072366)
1. Hydroa vacciniforme-like lymphoma: a case report from India.
Boddu D; George R; Nair S; Bindra M; G Mathew L
J Pediatr Hematol Oncol; 2015 May; 37(4):e223-6. PubMed ID: 25072366
[TBL] [Abstract][Full Text] [Related]
2. [Hydroa vacciniforme-like cutaneous T cell lymphoma: a case report and literature review].
Li HY; Wang HL; Gao TZ; Zhuo ZH; Li DM; Li HX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):596-8. PubMed ID: 19651001
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous hydroa vacciniforme-like lymphoma with indolent clinical course: report of two cases and review of literature.
Li Y; Chen XH; Tian XY; Li B; Li Z
Int J Surg Pathol; 2013 Apr; 21(2):161-8. PubMed ID: 22807582
[TBL] [Abstract][Full Text] [Related]
4. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma.
Plaza JA; Sangueza M
Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
Xu Z; Lian S
Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
[TBL] [Abstract][Full Text] [Related]
6. Hydroa Vacciniforme-Like EBV-Positive Cutaneous T-Cell Lymphoma, First Report of 2 Cases in Ecuador.
Montalvo N; Redrobán L
Am J Dermatopathol; 2016 May; 38(5):e57-9. PubMed ID: 26913846
[TBL] [Abstract][Full Text] [Related]
7. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases.
Sangueza M; Plaza JA
J Am Acad Dermatol; 2013 Jul; 69(1):112-9. PubMed ID: 23541598
[TBL] [Abstract][Full Text] [Related]
8. Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report.
Li J; Zan Y; Liu H; Liu H; Chen L
Medicine (Baltimore); 2018 Apr; 97(15):e0319. PubMed ID: 29642164
[TBL] [Abstract][Full Text] [Related]
9. Hydroa vacciniforme-like lymphoma in a patient from the Brazilian Amazon.
Santos M; Nogueira L; Talahri C; Massone C; Cerroni L; Mira MT; Talhari S
Int J Dermatol; 2013 May; 52(5):641-3. PubMed ID: 22512805
[No Abstract] [Full Text] [Related]
10. Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents.
Kim YJ; Choi SY; Lee WJ; Won CH; Chang SE; Choi JH; Lee MW
Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):287-290. PubMed ID: 28543883
[No Abstract] [Full Text] [Related]
11. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma.
Chen HH; Hsiao CH; Chiu HC
Br J Dermatol; 2002 Sep; 147(3):587-91. PubMed ID: 12207607
[TBL] [Abstract][Full Text] [Related]
12. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
[TBL] [Abstract][Full Text] [Related]
13. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults.
Rodríguez-Pinilla SM; Barrionuevo C; Garcia J; Martínez MT; Pajares R; Montes-Moreno S; Casavilca S; Montes J; Bravo F; Zaharia M; Zevallos-Giampietri E; Sanchez L; Piris MA
Am J Surg Pathol; 2010 Dec; 34(12):1773-82. PubMed ID: 21107082
[TBL] [Abstract][Full Text] [Related]
14. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
15. [Hydroa vacciniforme-like lymphoma: two cases report and literatures review].
Zhou L; Xu XJ; Zhang Y; Li HH; Wu S; Li YF; Li WC; Liu YQ
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):485-8. PubMed ID: 23827102
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
17. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.
Zeng Y; Fu L; Jin H; Sun Q; Wang B
Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of hydroa vacciniforme and malignant lymphoma.
Oono T; Arata J; Masuda T; Ohtsuki Y
Arch Dermatol; 1986 Nov; 122(11):1306-9. PubMed ID: 3490832
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
20. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
